Loading...
Brain+
powered by Stokk.io

Brain+ update: Commercial status and new opportunities

Mon, 25 Nov, 2024, 15:30 – 16:30
This event has ended. Sign up below to watch the recording.
Sign in to access all the features of the platform.

How does this Q&A work:

This company invites all interested, both current investors and potential investors to participate in this event, ask questions directly on this page before the event starts and upvote those questions you would like addressed.

The company will address as many questions as possible, and focus on those questions most wanted by investors.

Speakers at this event:

Kim Baden-Kristensen
CEO & Co-Founder
Hanne Vissing Leth
CFO
Devika Wood
CEO

6 Questions

N
Niels Raaschou
Nov. 25, 2024

Dear B+ - one more question from me - how is the competition looking in the UK ?
Is there any similar products / way of working ?
and if yes how far are they in the process - if You have any guesses for this please ?
Kind regards, Niels R.

K
Karsten Egtved
Nov. 23, 2024

Regarding sales in Denmark, like Vesthimmerland, is it trial versions, that can be upgraded/scaled up, to a larger contract, or is it a full contract fx for Vesthimmerland?

K
Karsten Egtved
Nov. 22, 2024

How are the sales, going in Denmark?

N
Niels Raaschou
Nov. 22, 2024

Dear B+,
Would it be possible to update the stockholders of cashburn ?, will there be any funding needs in 2025? - depending on any specific factors ? ,
I am aware of the data update from last Q-update - but would like to have an update if possible.

And for Devoka W. and the UK team - can you rate your optimisme for 2025 on a scale from 1-10 where 10 is "most optimistic" :-)

K
Karsten Egtved
Nov. 22, 2024

How are the financial health of NHS, going to affect Brain+ ability to make contracts with NHS?

K
Karsten Egtved
Nov. 22, 2024

Can you describe the sales process in UK, from first contact, to signing and payment. Do UK public healt sector, have the same fixed dates, for signing, and payments, as we have in Denmark?